On this episode: With over 20 years of experience in venture capital and degrees from MIT and Harvard, Dr. Jeff Himawan, Managing Director at EW Healthcare Partners, joins the show to discuss the role of venture capital in research-intensive pharmaceutical startups. Jeff outlines the impact that longer holding periods have on healthcare venture firms’ relationships with LPs as well as the characteristics needed to raise new financing rounds for pharma startups. Other topics include the impact of the pandemic on healthcare investing, the entrance of big tech into healthcare, and the lack of innovation by big pharma.